Domains of type 1 protein phosphatase inhibitor-2 required for nuclear and cytoplasmic localization in response to cell-cell contact
Author:
Leach Craig1, Eto Masumi1, Brautigan David L.1
Affiliation:
1. Center for Cell Signaling, University of Virginia School of Medicine, Box 800577-MSB7225, Charlottesville VA 22908, USA
Abstract
Inhibitor-2 of type 1 protein phosphatase is a phosphoprotein conserved among all eukaryotes, and it appears in both the nucleus and cytoplasm of tissue culture cells. We discovered that endogenous inhibitor-2 is concentrated in the nucleus of cells cultured at low density, whereas cells growing at high density excluded inhibitor-2 from the nucleus. There was rapid redistribution of inhibitor-2 when cells were replated at low or high density. Localization of myc-tagged forms of inhibitor-2 showed that residues 119-197 were required for nuclear accumulation in low-density cells and residues 78-119 were required for cytoplasmic localization in high-density cells. Fusion of inhibitor-2 residues 78-119 to green fluorescent protein was sufficient to produce cytoplasmic retention. Inhibitor-2 fused to triple tandem green fluorescent protein (100 kDa) was imported into the nucleus of low-density cells but was not excluded from the nucleus when cells reached high density, implying that inhibitor-2 was actively imported into the nucleus but exited by passive diffusion instead of active export. We conclude that inhibitor-2 contains two separate domains that control its localization in the nucleus or cytoplasm. This change in inhibitor-2 localization may direct inhibitor-2 to different forms of protein phosphatase 1 or change the localization of protein phosphatase, as part of the cellular response to cell-cell contacts at high density.
Publisher
The Company of Biologists
Reference26 articles.
1. Baba, M., Hirai, S., Kawakami, S., Kishida, T., Sakai, N.,Kaneko, S., Yao, M., Shuin, T., Kubota, Y., Hosaka, M. et al.(2001). Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth. Oncogene J.20, 2727-2736. 2. Bollen, M. (2001). Combinatorial control of protein phosphatase-1. Trends Biochem. Sci.26, 426-431. 3. Brautigan, D. L., Sunwoo, J., Labbe, J. C., Fernandez, A. and Lamb, N. J. C. (1990). Cell cycle oscillation of phosphatase inhibitor-2 in rat fibroblasts coincident with p34CDC2 restriction.Nature344, 74-78. 4. Bunge, R. G. L., Lieberman, M., Raben, D., Salzer, J.,Whittenberger, B. and Woolsey, T. (1979). Growth control by cell to cell contact. J. Supramol. Struct.11, 175-187. 5. Cannon, J. F., Pringle, J. R., Fiechter, A. and Khalil, M.(1994). Characterization of glycogen-deficient glcmutants of Saccharomyces cerevisiae.Genetics J.136, 485-503.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|